FAQs
The average price target represents 3.13% Increase from the current price of $140.79. Quest Diagnostics's analyst rating consensus is a Hold. This is based on the ratings of 11 Wall Streets Analysts.
How much market share does Quest Diagnostics have? ›
DGX's vs. Market share relative to its competitors, as of Q1 2024
| COMPANY NAME | REVENUES 12 Months Ending Q1 2024 | MARKET SHARE MRQ Q1 2024 |
|---|
| Quest Diagnostics Inc | 9,287.00 | 41.52 % |
| Neogenomics Inc | 609.85 | 2.73% |
| Laboratory Corporation Of America Holdings | 11,560.30 | 55.75% |
| SUBTOTAL | 21,457.15 | 5,698.07 |
May 1, 2024
Financial PerformanceAnalyst recommendation for DGX stock is a Buy, with a raised price target to $155, based on strong Q1 performance and positive business trends.
What is Quest Diagnostics price target? ›
The average twelve-month price prediction for Quest Diagnostics is $146.17 with a high price target of $160.00 and a low price target of $130.00. Learn more on DGX's analyst rating history.
Who is the largest shareholder of Quest Diagnostics? ›
Top Holders: Mutual Funds
| Shares Held | Filing Date |
|---|
| The Vanguard Group, Inc. | 13,921,955 | 03/31/2024 |
| BlackRock, Inc. | 10,700,573 | 03/31/2024 |
| State Street Corporation | 5,199,194 | 03/31/2024 |
| Victory Capital Management Inc. | 3,922,331 | 03/31/2024 |
21 more rowsAnalysts estimate adjusted profit to be $8.75 per share. It also raised its 2024 revenue forecast to $9.40 billion to $9.48 billion from its previous outlook of $9.35 billion to $9.45 billion.
Is Quest a Fortune 500 company? ›
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Is Quest Diagnostics laying off employees? ›
Quest also said it's reducing its headcount by about 1.5% to lower its costs by $100 million this year. Corporate support functions will account for most of the layoffs. The company expects to see a modest benefit from the cuts in the first quarter with bigger savings arriving later in the year.
Is DGX a good stock to buy? ›
Out of 9 analysts, 3 (33.33%) are recommending DGX as a Strong Buy, 0 (0%) are recommending DGX as a Buy, 6 (66.67%) are recommending DGX as a Hold, 0 (0%) are recommending DGX as a Sell, and 0 (0%) are recommending DGX as a Strong Sell.
What is target highest stock? ›
The latest closing stock price for Target as of May 21, 2024 is 155.78. The all-time high Target stock closing price was 249.25 on November 16, 2021.
Strictly defined, a target price is an estimate of a stock's future price, based on earnings forecasts and assumed valuation multiples. This article investigates what people should know about target prices, and how these reports can lead to wiser investment decisions.
What are the goals of Quest Diagnostics? ›
We're dedicated to providing actionable results that empower you with the information you need to make your healthcare decisions count through: Discovering new ways to screen for, prevent, diagnose, and monitor disease.
How big is the lab diagnostics market? ›
The U.S. diagnostic testing market size was valued at USD 84.85 billion in 2023 and is anticipated to reach around USD 158.77 billion by 2033, growing at a CAGR of 6.5%% from 2024 to 2033. The diagnostic testing market in North America is thriving, primarily fueled by the region's expanding elderly population.
How reliable are price targets? ›
Are Price Targets Accurate? Despite the best efforts of analysts, a price target is a guess with the variance in analyst projections linked to their estimates of future performance. Studies have found that, historically, the overall accuracy rate is around 30% for price targets with 12-18 month horizons.
